Clinical Trials Browser

Metastatic Colorectal Cancer With Left-sided Primary Tumor × Bevacizumab × Clear all

NCT07070713 2025-07-17

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

Phase 2 Not yet recruiting

Gastrointestinal

Metastatic Colorectal Cancer With Left-sided Primary Tumor